Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6970641rdf:typepubmed:Citationlld:pubmed
pubmed-article:6970641lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6970641lifeskim:mentionsumls-concept:C0026769lld:lifeskim
pubmed-article:6970641lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:6970641lifeskim:mentionsumls-concept:C0007806lld:lifeskim
pubmed-article:6970641lifeskim:mentionsumls-concept:C0080202lld:lifeskim
pubmed-article:6970641lifeskim:mentionsumls-concept:C2362651lld:lifeskim
pubmed-article:6970641lifeskim:mentionsumls-concept:C1823153lld:lifeskim
pubmed-article:6970641lifeskim:mentionsumls-concept:C2349976lld:lifeskim
pubmed-article:6970641lifeskim:mentionsumls-concept:C1552644lld:lifeskim
pubmed-article:6970641pubmed:issue2lld:pubmed
pubmed-article:6970641pubmed:dateCreated1981-5-28lld:pubmed
pubmed-article:6970641pubmed:abstractTextProportions of T cells and T cell subsets, as identified by their Fc receptors (FcR) for IgM and IgG (Tmu and T gamma), were determined in the peripheral blood lymphocyte (PBL) and cerebrospinal fluid (CSF) lymphocyte populations in patients with multiple sclerosis (MS). On average, MS patients had 79% total T cells (62% of which were T gamma, 66% Tmu) in CSF lymphocytes compared to 66% total T cells (30% T gamma, 63% Tmu) in PBL. Normal age- and sex-matched controls PBL had 74% total T cells (20% T gamma, 54% Tmu). By direct observation using an indirect immunofluorescence assay, 41% of the CSF T gamma cells in MS patients bore receptors for IgM; these cells were designated T gamma mu and, according to the double-marker analysis, did not seem to correlate with disease stage. In MS PBL, 20% of T gamma cells were T gamma mu compared to 9% in the control PBL T gamma population. Thus, MS patients had a higher proportion of total T cells, T gamma cells and T gamma mu cells in their CSF than in their peripheral blood and than those populations found in normal control blood. The significance of this T gamma mu population for the continuing disease state in MS is discussed.lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:languageenglld:pubmed
pubmed-article:6970641pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:citationSubsetIMlld:pubmed
pubmed-article:6970641pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6970641pubmed:statusMEDLINElld:pubmed
pubmed-article:6970641pubmed:monthNovlld:pubmed
pubmed-article:6970641pubmed:issn0009-9104lld:pubmed
pubmed-article:6970641pubmed:authorpubmed-author:BiberfeldGGlld:pubmed
pubmed-article:6970641pubmed:authorpubmed-author:NorrbyEElld:pubmed
pubmed-article:6970641pubmed:authorpubmed-author:SidénAAlld:pubmed
pubmed-article:6970641pubmed:authorpubmed-author:MerrillJ EJElld:pubmed
pubmed-article:6970641pubmed:authorpubmed-author:LandinSSlld:pubmed
pubmed-article:6970641pubmed:issnTypePrintlld:pubmed
pubmed-article:6970641pubmed:volume42lld:pubmed
pubmed-article:6970641pubmed:ownerNLMlld:pubmed
pubmed-article:6970641pubmed:authorsCompleteYlld:pubmed
pubmed-article:6970641pubmed:pagination345-54lld:pubmed
pubmed-article:6970641pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:6970641pubmed:meshHeadingpubmed-meshheading:6970641-...lld:pubmed
pubmed-article:6970641pubmed:meshHeadingpubmed-meshheading:6970641-...lld:pubmed
pubmed-article:6970641pubmed:meshHeadingpubmed-meshheading:6970641-...lld:pubmed
pubmed-article:6970641pubmed:meshHeadingpubmed-meshheading:6970641-...lld:pubmed
pubmed-article:6970641pubmed:meshHeadingpubmed-meshheading:6970641-...lld:pubmed
pubmed-article:6970641pubmed:meshHeadingpubmed-meshheading:6970641-...lld:pubmed
pubmed-article:6970641pubmed:meshHeadingpubmed-meshheading:6970641-...lld:pubmed
pubmed-article:6970641pubmed:meshHeadingpubmed-meshheading:6970641-...lld:pubmed
pubmed-article:6970641pubmed:meshHeadingpubmed-meshheading:6970641-...lld:pubmed
pubmed-article:6970641pubmed:meshHeadingpubmed-meshheading:6970641-...lld:pubmed
pubmed-article:6970641pubmed:meshHeadingpubmed-meshheading:6970641-...lld:pubmed
pubmed-article:6970641pubmed:meshHeadingpubmed-meshheading:6970641-...lld:pubmed
pubmed-article:6970641pubmed:year1980lld:pubmed
pubmed-article:6970641pubmed:articleTitleIdentification of three FcR-positive T cell subsets (T gamma, T mu and T gamma mu) in the cerebrospinal fluid of multiple sclerosis patients.lld:pubmed
pubmed-article:6970641pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6970641pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6970641pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6970641lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6970641lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6970641lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6970641lld:pubmed